Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 343

recruiting
3 967
countries
28
conditions
2 124

10 514 trials match your criteria

Obesity+2

Not yet recruiting

Phase 3 Study of Once‑Monthly PF‑08653944 for Pain Relief in Adults with Knee Osteoarthritis and Overweight or Obesity

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Berobenatide

Cardiovascular disorder+2

Not yet recruiting

Phase III Study Evaluating Efficacy and Safety of Petrelintide in Participants with Overweight or Obesity and Established Cardiovascular Disease

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Petrelintide

Pruritus

Not yet recruiting

Efficacy and safety of remibrutinib, pimecrolimus and tacrolimus in adults with severe chronic pruritus of unknown origin (CPUO): a randomized, placebo‑controlled trial

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Pimecrolimus

Crohn's disease

Not yet recruiting

Clinical trial of subcutaneous infliximab in patients with perianal fistulizing Crohn’s disease

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Infliximab

Bronchiectasis

Not yet recruiting

Efficacy and safety of galvokimig in adults with non‑cystic fibrosis bronchiectasis: a randomized, double‑blind, placebo‑controlled phase 2 trial

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Galvokimig

Chronic lymphocytic leukaemia+1

Not yet recruiting

Phase II Study of Zanubrutinib in Elderly, Treatment‑Naïve Patients with Chronic Lymphocytic Leukemia

Registered drugNo placebo
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Zanubrutinib

Colitis ulcerative

Not yet recruiting

Evaluation of the Efficacy and Safety of Ponesimod in Patients with Moderate to Severe Ulcerative Colitis

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Ponesimod

Randomized phase III study of AAA817 plus an androgen receptor pathway inhibitor in adult men with PSMA‑positive metastatic castration‑resistant prostate cancer

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone

Acute coronary syndrome

Not yet recruiting

Early LDL‑cholesterol reduction with rosuvastatin drug combination in patients with acute coronary syndrome

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Alirocumab

Abdominal infection+4

Not yet recruiting

Study of Subcutaneous Ceftazidime and Avibactam in Adults with Complicated Intra‑Abdominal, Urinary Tract, or Hospital‑Acquired Pneumonia Infections

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Avibactam

Spinal muscular atrophy

Not yet recruiting

Safety and tolerability of intracisternal GNT0009 gene therapy plus drug combination in patients with spinal muscular atrophy with progressive myoclonic epilepsy (SMA‑PME)

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Eculizumab

Embolism

Not yet recruiting

Safety, Tolerability and Pharmacokinetics of Milvexian in Pediatric Patients at Risk of Thromboembolic Events (28 Days to <18 Years)

InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:0–17 years
  • Substances:Milvexian
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.